The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day
The Oncology Institute (NASDAQ: TOI) will host a Fireside Chat featuring CEO Brad Hively and CFO Mihir Shah during the Baird Newly Public Company Virtual Access Day on August 17, 2022, at 2:20 PM EST.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) will host a Fireside Chat featuring CEO Brad Hively and CFO Mihir Shah during the Baird Newly Public Company Virtual Access Day on August 17, 2022, at 2:20 PM EST. Interested investors can access the live webcast through the Investor Relations section of the company’s website. The Oncology Institute focuses on advancing value-based community oncology, serving around 1.7 million patients with over 90 clinicians across 50+ locations. For further information, visit theoncologyinstitute.com.
Details
News Market Reaction – TOI
The recorded move for TOI in the trading session of this news was +9.21%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, and its Chief Financial Officer, Mihir Shah, will participate in the Baird Newly Public Company Virtual Access Day on Wednesday, August 17 at 2:20pm EST.
Interested investors and other parties may listen to simultaneous webcasts of the Fireside Chat by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/. The online replay will be available for a limited time shortly following the conference.
About The Oncology Institute, Inc.
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.7 million patients including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 90+ employed clinicians and more than 700 teammates in over 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
Contacts
Media
The Oncology Institute
Julie Korinke
juliekorinke@theoncologyinstitute.com
(562) 735-3226 x 88806
Investors
Solebury Trout
Maria Lycouris
investors@theoncologyinstitute.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.